增生型糖尿病视网膜病变手术的研究进展  

Research progress of surgery for proliferative diabetic retinopathy

作　　者：潘越 李文博 胡博杰 Pan Yue;Li Wenbo;Hu Bojie(Tianjin Key Laboratory of Retinal Functions and Diseases,Tianjin Branch of National Clinical Research Center for Ocular Disease,Eye Institute and School of Optometry,Tianjin Medical University Eye Hospital,Tianjin 300384,China)

机构地区：[1]天津医科大学眼科医院、眼视光学院、眼科研究所国家眼耳鼻喉疾病临床医学研究中心天津市分中心,天津市视网膜功能与疾病重点实验室,天津300384

出　　处：《中华眼底病杂志》2024年第11期887-892,共6页Chinese Journal of Ocular Fundus Diseases

基　　金：天津市医学重点学科(专科)建设项目(TJYXZDXK-037A);天津市教委科研计划项目(自然科学)(2022ZD058);天津市滨海新区卫生健康委项目(2023BWKZ006)。

摘　　要：增生型糖尿病视网膜病变是糖尿病在眼部的严重并发症,可导致严重视力下降甚至完全的视力丧失。近年来,随着手术设备和眼底检查技术的快速发展,基于玻璃体切割手术的治疗方法在适应证范围、手术技术改进和应用、与药物(抗血管内皮生长因子药物,糖皮质激素)联合应用,以及手术评估等方面均取得了新的进展。以影像学为主的手术评估可以在手术前、手术中、手术后对患者眼部情况进行连贯监测,临床医生可以对不同患者进行不同的手术方案和手术时机的选择,有助于减轻患者痛苦,获得更好的视力结局。Proliferative diabetic retinopathy is a serious complication of diabetes in the eye that can lead to severe vision loss or even complete vision loss.In recent years,with the rapid development of surgical equipment and fundus examination technology,the indications for pars plana vitrectomy based surgical treatment have been expanded,surgical improvement and application,combined application of drugs,such as anti-vascular endothelial growth factor drugs,glucocorticoids,and surgical evaluation have made new progress.Surgical evaluation based on imaging can continuously monitor patients'eye conditions before,during and after surgery,and clinicians can choose different surgical plans and timing for different patients,which can help reduce patients'pain and achieve better visual outcomes.

关 键 词：增生型糖尿病视网膜病变 玻璃体切除手术 糖尿病黄斑水肿 综述 

分 类 号：R587.2[医药卫生—内分泌] R779.6[医药卫生—内科学]